Charlene Mantia, Chang Gon Kim, Jordi Rodon Ahnert, Omar Alhalabi, Alexander Z Wei, Mark N. Stein, Melissa Lynne Johnson, Benjamin Garmezy, Alok Tewari, Sid Devarakonda, Abhishek Tripathi, Benedito A. Carneiro, Inkeun Park, Valentina Boni, Emily Liu, Jasgit C. Sachdev, Mick O'Quigley, Claire Neilan, Darrin M. Beaupre, Hye Ryun Kim. "Phase 1 dose escalation (DEs) & expansion (DEx) study to evaluate the safety & efficacy of IDE397 plus sacituzumab-govitecan in patients with advanced urothelial carcinoma (UC) with MTAP deletion (MTAPdel).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps892